2023-09-05 06:42:18 ET
More on Viatris
- Seeking Alpha’s Quant Rating on Viatris
- Historical earnings data for Viatris
- Dividend scorecard for Viatris
- Financial information for Viatris
- Viatris Emerges As Challenger In Lucrative Anti-Obesity Drugs market
- Viatris: Turning Point For Cheap Pharma Stock
- Viatris Inc. ( VTRS ) Q2 2023 Earnings Call Transcript
- Generic drug prices have dropped significantly since 2006 - report
- Viatris goes ex-dividend today
- S&P changes outlook on Viatris to negative
- Viatris multiple sclerosis therapy accepted for FDA review
For further details see:
Viatris wins tentative FDA approval for HIV therapy in children